These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 32118502)

  • 21. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis.
    Chow R; Novosel M; So OW; Bellampalli S; Xiang J; Boldt G; Winquist E; Lock M; Lustberg M; Prsic E
    BMJ Support Palliat Care; 2023 Mar; 13(1):27-34. PubMed ID: 36194493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of drug therapy for the prevention and treatment of chemotherapy-induced peripheral neuropathy: a protocol for a systematic review and network meta-analysis.
    Sato MT; Hasegawa T; Noma H; Sugita H; Ota E
    BMJ Open; 2023 Sep; 13(9):e070645. PubMed ID: 37699621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy.
    Avallone A; Bimonte S; Cardone C; Cascella M; Cuomo A
    Anticancer Res; 2022 Oct; 42(10):4667-4678. PubMed ID: 36191965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
    Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS
    Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    Aziz MT; Good BL; Lowe DK
    Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models.
    Bouchenaki H; Danigo A; Sturtz F; Hajj R; Magy L; Demiot C
    Fundam Clin Pharmacol; 2021 Jun; 35(3):506-523. PubMed ID: 33107619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms.
    Tanay MAL; Armes J; Moss-Morris R; Rafferty AM; Robert G
    J Cancer Surviv; 2023 Feb; 17(1):254-277. PubMed ID: 33710510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy-induced peripheral neuropathy and neuropathic pain].
    Schuler U; Heller S
    Schmerz; 2017 Aug; 31(4):413-425. PubMed ID: 28293734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.
    Sałat K
    Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment.
    Majithia N; Loprinzi CL; Smith TJ
    Oncology (Williston Park); 2016 Nov; 30(11):1020-9. PubMed ID: 27854104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.
    Ma J; Kavelaars A; Dougherty PM; Heijnen CJ
    Cancer; 2018 Jun; 124(11):2289-2298. PubMed ID: 29461625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Hoshino N; Ganeko R; Hida K; Sakai Y
    Int J Clin Oncol; 2018 Jun; 23(3):434-442. PubMed ID: 29270698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
    Mansooralavi N; Khomula EV; Levine JD
    Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
    Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.
    Loprinzi C; Le-Rademacher JG; Majithia N; McMurray RP; O'Neill CR; Bendel MA; Beutler A; Lachance DH; Cheville A; Strick DM; Black DF; Tilburt JC; Smith TJ
    Support Care Cancer; 2020 Mar; 28(3):1183-1197. PubMed ID: 31209630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of peripheral neuropathy induced by chemotherapy in adults with cancer: a review.
    Al-Atiyyat N; Obaid A
    Int J Palliat Nurs; 2017 Jan; 23(1):13-17. PubMed ID: 28132604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
    Misawa S; Denda T; Kodama S; Suzuki T; Naito Y; Kogawa T; Takada M; Suichi T; Shiosakai K; Kuwabara S;
    BMC Cancer; 2023 Nov; 23(1):1098. PubMed ID: 37951905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.
    Kanzawa-Lee GA; Knoerl R; Donohoe C; Bridges CM; Smith EML
    Semin Oncol Nurs; 2019 Jun; 35(3):253-260. PubMed ID: 31053396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.